Satellos Bioscience Inc.

TSX:MSCL.TO

Biotechnology

Healthcare
$8.62 +0.12%

+$0.01 today

Market cap
$182.89M
Beta
1.17
P/E (TTM)
-1.8
EPS (TTM)
-$0.32
52W Low $6.36High $18.98

Volume 0.01M

Average 0.02M

Balance Sheet

Inspect the capital base behind the business.

Assets

$31.83M

FY 2025 · Annual

-56.4% YoY

Liabilities

$4.10M

FY 2025 · Annual

-20.5% YoY

Equity

$27.73M

FY 2025 · Annual

-59.1% YoY

Balance Sheet

Mixed currencies
Metric
FY2021
Dec 2021 · CAD
FY2022
Dec 2022 · CAD
FY2023
Dec 2023 · CAD
FY2024
Dec 2024 · CAD
FY2025
Dec 2025 · USD
Cash & Equivalents4.87M1.92M22.07M57.66M9.79M
Short-term Investments0017.52M12.2M17.87M
Net Receivables527.98K260.44K583K626K369.33K
Inventory00000
Other Current Assets02.57K4K0(6.92K)
Total Current Assets5.44M2.23M40.32M73.01M31.83M
Property, Plant & Equipment (Net)8.19K9K19K5K4.99K
Goodwill0(190)000
Intangible Assets7.14M3.92M3.92M00
Long-term Investments042K41K00
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets7.14M3.97M3.98M5K4.99K
Total Assets12.59M6.2M44.3M73.02M31.83M
Account Payables1.13M1.47M1.04M2.97M1.77M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities0000(7.47K)
Total Current Liabilities2.1M2.83M3.62M5.16M4.1M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities00000
Total Liabilities2.1M2.83M3.62M5.16M4.1M
Common Stock28.32M30.21M61.92M105.73M85.67M
Retained Earnings(20.29M)(31.61M)(47.5M)(75.6M)(81.82M)
Accumulated OCI(1.44K)1.09M21.24M(217K)13.73M
Other Stockholders Equity00027.62M0
Minority Interest00000
Total Equity10.48M3.37M40.67M67.86M27.73M
Total Debt00000
Net Debt(4.87M)(1.92M)(22.07M)(57.66M)(9.79M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$18.7M
Short-term Investments$51.3M
Receivables$726.5K
Other Current$4.6M
Total Current Assets$75.3M
PP&E (Net)$8.0K
Total Non-current Assets$8.0K
Total Assets$75.3M

Analysis

Selected assets total $75.3M for Latest. The largest visible component is Short-term Investments at $51.3M, about 68.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

No filings found.

How much cash does MSCL.TO have?

Satellos Bioscience Inc. (MSCL.TO) reported $9.79M in cash and equivalents in fiscal 2025.

How much debt does MSCL.TO carry?

Satellos Bioscience Inc. (MSCL.TO) reported $0.00 of total debt, with net debt of -$9.79M.